CIK 0001805385 · Non-accelerated filer
Evolv Technologies Holdings, Inc.
Sign in to watch- Ticker
- EVLV
- Exchange
- Nasdaq
- Industry
- Computer Peripheral Equipment, NEC
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 844473840
- Phone
- 781-374-8100
- Business address
- 500 TOTTEN POND ROAD, 4TH FLOOR, WALTHAM, MA, 02451
- Former names
- NewHold Investment Corp.
- Open-market buys, last 90 days
- $296,479
- in 3 filings
- Open-market sales, last 90 days
- $451,404
- in 1 filing, $451K under 10b5-1 plans
Net −$154,925. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Ellenbogen Michael Director | Grant or award · Restricted Stock Units | +3,731 | 3,731 | ||
| 2026-01-02 | Sullivan Mark J. Director | Grant or award · Restricted Stock Units | +3,731 | 3,731 | ||
| 2025-12-31 | Sullivan Mark J. Director | Option exercise | +7,575 | 215,578 | ||
| 2025-12-31 | Sullivan Mark J. Director | Option exercise · Restricted Stock Units | −7,575 | 0 | ||
| 2025-12-15 | Ellenbogen Michael Director | Option exercise 10b5-1 | +80,745 | $0.24 | $19K | 2,164,706 |
| 2025-12-15 | Ellenbogen Michael Director | Sale 10b5-1 | −80,745 | $6.91 | $558K | 2,083,961 |
| 2025-12-15 | Ellenbogen Michael Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −80,745 | 1,381,484 | ||
| 2025-11-25 | Marshall Robert E Chief Revenue Officer | Purchase | +7,000 | $6.06 | $42K | 7,000 |
| 2025-11-21 | Kedzierski John President & CEO | Purchase | +8,000 | $5.91 | $47K | 8,000 |
| 2025-11-21 | Charlton Kevin M. Director | Purchase | +15,000 | $5.68 | $85K | 44,081 |
| 2025-11-20 | Shapiro Richard A Director | Purchase | +30,000 | $6.00 | $180K | 52,515 |
| 2025-11-20 | Shapiro Richard A Director | Purchase | +7,500 | $6.02 | $45K | 22,500 |
| 2025-11-20 | Shapiro Richard A Director | Purchase | +8,800 | $6.02 | $53K | 16,400 |
| 2025-11-17 | Ellenbogen Michael Director | Option exercise 10b5-1 | +80,745 | $0.24 | $19K | 2,164,706 |
| 2025-11-17 | Ellenbogen Michael Director | Sale 10b5-1 | −80,745 | $5.80 | $468K | 2,083,961 |
| 2025-11-17 | Ellenbogen Michael Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −80,745 | 1,462,229 | ||
| 2025-10-27 | Chitkara Anil Founder & Chief Growth Officer | Option exercise 10b5-1 | +85,173 | $0.24 | $20K | 1,360,273 |
| 2025-10-27 | Chitkara Anil Founder & Chief Growth Officer | Option exercise 10b5-1 | +34,827 | $0.42 | $15K | 1,395,100 |
| 2025-10-27 | Chitkara Anil Founder & Chief Growth Officer | Sale 10b5-1 | −120,000 | $8.20 | $984K | 1,275,100 |
| 2025-10-27 | Chitkara Anil Founder & Chief Growth Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −85,173 | 783,324 |
Page 5 of 27 · 526 trades